Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome

Diabetes Research and Clinical Practice

Volumn 77, Issue 3 SUPPL., 2007, Pages

  Park, Hwi Ra ^a   Choi, Youngju ^a   Lee, Hye Jin ^a   Oh, Jee Young ^a   Hong, Young Sun ^a   Sung, Yeon Ah ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Insulin sensitivity; Phenotype; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KOREA; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PHENOTYPE;

ADULT; BODY MASS INDEX; BODY WEIGHT; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; KOREA; MENSTRUAL CYCLE; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; REFERENCE VALUES;

EID: 34547663204     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.01.063     Document Type: Article

References (20)

1. Dunaif A., and Thomas A. Current concepts in the polycystic ovary syndrome. Annu. Rev. Med. 52 (2001) 401-419
2. Asuncion M., Calvo R.M., San Millan J.L., Sancho J., Avila S., and Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab. 85 (2000) 2434-2438
3. Legro R.S., Kunselman A.R., Dodson W.C., and Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84 (1999) 165-169
4. Palmert M.R., Gordon C.M., Kartashov A.I., Legro R.S., Emans S.J., and Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87 (2002) 1017-1023
5. Solomon C.G., Hu F.B., Dunaif A., Rich-Edwards J., Willett W.C., Hunter D.J., et al. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 286 (2001) 2421-2426
6. Azziz R., Ehrmann D., and Legro R.S. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 86 (2001) 1626-1632
7. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Teatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Third report, Circulation 106 (2002) 3143-3421.
8. Cibula D. Is insulin resistance an essential component of PCOS? The influence of confounding factors. Hum. Reprod. 19 (2004) 757-759
9. Holte J., Bergh T., Berne C., Berglund L., and Lithell H. Enhanced insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J. Clin. Endocrinol. Metab. 78 (1994) 1052-1058
10. Cibula D., Sindelka G., Hill M., Fanta M., Skrha J., and Zivny J. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin. Hum. Reprod. 17 (2002) 76-82
11. Ovesen P., Moller J., Ingerslev H.J., Jorgensen J.O., Mengel A., Schmits O., et al. Normal basal and insulin-stimulated fuel metabolism in lean women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 77 (1993) 1636-1640
12. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
13. Toprak S., Yonem A., Cakir B., Guler S., Azal O., Ozata M., et al. Insulin resistnace in non-obese patients with polycystic ovary syndrome. Hormone Res. 55 (2001) 65-70
14. Dunaif A., Segal K.R., Shelly D.R., Green G., Dobrjansky A., and Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes Care 41 (1992) 1257-1266
15. Zawadski J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: Dunaif A., Givens J.R., and Haseltine F. (Eds). Polycystic Ovary Syndrome (1992), Blackwell Scientific, Boston 377-384
16. Lobo R.A., Kletzky O.A., campeau J.D., and di Zerega G.S. Elevated bioactive luteinizing hormones in women with polycystic ovary syndrome. Fertil. Steril. 39 (1983) 674-678
17. Kauffman R.P.P., Baker V.M., DiMarino P., and Castracane V.D. Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome. Fertil. Steril. 85 (2006) 1010-1016
18. Kumar A., Woods K.S., Bartolucci A.A., and Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome. Clin. Endocrinol. 62 (2005) 644-649
19. Moran C., Garcia-Henandez E., Barahona E., Gonzalez S., and Bermudez J. Relationship between gonadotropin dissociation in obese and non-obese women with polycystic ovary syndrome. Fertil. Steril. 80 (2003) 1466-1472
20. Panidis D., Koliakos G., Kourtis A., Farmakiotis D., Mouslech T., and Rousso D. Serum resistin levels in women with polycystic ovary syndrome. Fertil. Steril. 81 (2004) 361-366